SEC Form 4 · accession 0001193125-26-274301
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Shepard
Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 17, 2026 · 4:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 16, 2026 | A | 63,481 | $0.00 | A | 235,036 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.